Steven Cohen’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.7M Buy
61,300
+50,900
+489% +$18.9M 0.03% 785
2026
Q1
$3.04M Sell
10,400
-12,600
-55% -$4.14M ﹤0.01% 2033
2025
Q4
$8.06M Buy
23,000
+21,500
+1,433% +$7.27M 0.01% 1489
2025
Q3
$485K Buy
1,500
+700
+88% +$218K ﹤0.01% 1934
2025
Q2
$311K Hold
800
﹤0.01% 1908
2025
Q1
$348K Sell
800
-2,700
-77% -$1.08M ﹤0.01% 1719
2024
Q4
$1.29M Sell
3,500
-9,900
-74% -$4.14M ﹤0.01% 1404
2024
Q3
$6.97M Buy
13,400
+100
+0.8% +$53.4K 0.02% 778
2024
Q2
$7.21M Buy
13,300
+4,600
+53% +$2.43M 0.02% 731
2024
Q1
$4.51M Buy
+8,700
New +$4.33M 0.01% 994
2023
Q2
Sell
-7,000
Closed -$3.22M 2323
2023
Q1
$3.22M Buy
7,000
+3,900
+126% +$1.86M 0.01% 897
2022
Q4
$1.59M Buy
3,100
+1,600
+107% +$812K 0.01% 978
2022
Q3
$681K Hold
1,500
﹤0.01% 1124
2022
Q2
$724K Buy
+1,500
New +$742K ﹤0.01% 1138
2020
Q4
Sell
-100,000
Closed -$26.9M 963
2020
Q3
$26.9M Buy
+100,000
New +$26.9M 0.14% 208

Other funds holding ELV

Steven Cohen's ELV Position: Q2 2026 in Review

Steven Cohen sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 59,341 shares — an estimated $22M sold.

Steven Cohen first reported a position in ELV in Q2 2014 and held it in 26 quarters. The position peaked at $173M in Q1 2019. 1,596 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Steven Cohen reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Steven Cohen sold 59,341 Elevance Health shares in Q2 2026, an estimated $22M.
  • Steven Cohen first reported a position in Elevance Health in Q2 2014 and held it in 26 quarters.
  • Steven Cohen's Elevance Health position peaked at $173M in Q1 2019.
  • 1,596 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.